Depressive symptoms and non-adherence to treatable cardiovascular risk factors' medications in the CONSTANCES cohort.
Nadine M HamiehSofiane KabMarie ZinsJacques BlacherPierre MenetonJean Philippe EmpanaNicolas HoertelFrederic LimosinMarcel GoldbergMaria MelchiorCédric LemognePublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Non-adherence to medications targeting treatable cardiovascular risk factors is unlikely to explain much of the association between depressive symptoms and CVD at a population level. Clinicians are urged to search for and treat depression in individuals with diabetes to foster medications adherence.